London's FTSE 250 was down 0.3% to 16,713.91 as markets nudged lower following the release of weaker-than-expected US non-farm payrolls.
1630:Close Stocks bounced back on the last day of the week with some market commentary pointing to increased certainty regarding the outlook following Janet Yellen's speech overnight. In particular, she explicitly positioned herself among those at the Fed who think a rate hike later in 2015 is "more likely". A slightly larger than expected revision to US second quarter GDP figures may also have lent a helping hand. Overnight, the MPC's McCafferty repeated his stance in favour of rate hikes now. Commodity stocks led on the downside. Glencore shares finished lower after a brief spike towards the close of trading on the back of reports about asset sales. Johnson Matthey was near the top of the leaderboard following very positive comments out of Redburn. FTSE 100 up 147.52 points to 6,109.01.
The FTSE 250 was up 287.23 points or 1.74% to 16,801.76, rising sharply on Friday morning on the back of Janet Yellen's comments overnight.
Shares in Synergy Health rocketed on Friday after it announced that a federal court in Ohio has ruled against the Federal Trade Commission's request for a preliminary injunction to block Steris' $1.9bn acquisition of the group.
Synergy Health said no decision has been made yet on the US Federal Trade Commission's attempt to block the company's takeover by Steris Corp.
Health services firm Synergy said first quarter revenue was up by 9% in a trading announcement on Thursday.
Mid-caps tracked the FTSE 100's gains on Wednesday afternoon despite mixed US data, as strength in the construction and engineering sectors buoyed the market.
Synergy Health posted a 7.5% jump in full-year revenue despite adverse currency translation effects and said it was well placed to sustain its growth over both the medium and long-term.
British American Tobacco: JP Morgan reiterates overweight and 4,100p target price.
As has been feared, Synergy Health's takeover by US rival Steris Corp has been blocked by US competition regulators, but the two companies announced on Friday that they will contest the ruling and some analysts remained surprised by the regulator's stance.
Numis has suspended its rating on Synergy Health on news that it is contesting against a decision by US competition regulators to block its takeover by US rival Steris Corp.
UK stocks were subdued on Thursday, following weak economic data and continued investor uncertainty on Greek developments. Sector-wise, strong performances from technology and retail was outweighed by weakness in telecommunications and mining.
Stocks erased losses to push into positive territory by Thursday lunchtime despite some disappointing UK economic data, as investors continued to focus on newsflow from Greece.
Stocks opened in the red on Thursday as investors took profits following a surge the day before, with renewed uncertainty in Greece hitting sentiment.
UK stocks rebounded from the previous session's sell-off as gains made by tobacco, electronics and utilities outweighed weakness in mining and industrial metals.
Investors managed to take advantage of a quiet morning to push UK stocks higher on Wednesday following a sell-off the previous day.
UK stocks rebounded slightly on Wednesday morning after a sharp sell-off the previous session, with investors awaiting the Queen's Speech on a quiet day in terms of economic and corporate news.
Shares in Synergy Health were registering sharp losses on speculation US authorities were about to block its proposed takeover by New York-listed rival Steris.
Afren's share price was extending Friday's losses when the company proposed a debt-for-equity swap with lenders to keep it afloat. The deal will lead to a substantial dilution of shareholders' interests.
A late rally helped the FTSE 100 to erase most of its losses on Wednesday as optimism surrounding Greece and stimulus measures in China lifted sentiment, though stocks still finished in the red after hitting a five-month high the previous day.